BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes.

The role of HDL- and non-HDL-related parameters in cell-cholesterol efflux capacity.

Plasma fatty acid profiles: Relationships with sex, age, and state-reported heart disease mortality rates in the United States.

Targeted next-generation sequencing in a large series of fetuses with severe renal diseases.

Structural mapping of GABRB3 variants reveals genotype-phenotype correlations.

Clinical Utility of a Unique Genome-Wide DNA Methylation Signature for KMT2A-Related Syndrome.

Correction to: Assessment of Comorbidity Burden and Treatment Response: Reanalysis of the SCD-HEFT Trial.

Assessment of Comorbidity Burden and Treatment Response: Reanalysis of the SCD-HEFT Trial.

Hepatitis B and Hepatitis C Virus Infection Promote Liver Fibrogenesis through a TGF-β1-Induced OCT4/Nanog Pathway.

An exploratory analysis of the competing effects of alcohol use and advanced hepatic fibrosis on serum HDL.

Body composition during the first 4 months in infants affected by neonatal abstinence syndrome: a pilot study.

MYT1L-associated neurodevelopmental disorder: description of 40 new cases and literature review of clinical and molecular aspects.

Substance use disorder is associated with alcohol-associated liver disease in patients with alcohol use disorder.

The association between state-based provisional attendance periods and adolescent middle school-entry vaccination coverage.

Synthesis and Pharmacological Characterization of Visabron, a Backbone Cyclic Peptide Dual Antagonist of ι4β1 (VLA-4)/ι9β1 Integrin for Therapy of Multiple Sclerosis.